study about regeneration potential of patients own blood product and synthetic bone graft material in bone defects caused by gum diseases.

Efficacy of autologous platelet rich fibrin (PRF)and Sree Chitra Hydroxy apatite bioactive glass (HABG)in the management of localized intra bony defects -A randomized controlled Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/04/002610

Enrollment

Registered

2012-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic localized moderate to severe periodontitis,with localized intrabony defects

Interventions

Intervention1: platelet rich fibrin and sreechitra hydroxy apatite bioactive glass are used in bone defects caused by periodontal diseases during surgical procedure and the patients will be evaluated

Eligibility

Inclusion criteria

Inclusion criteria: patients diagnosed with localized chronic moderate or localized agressive periodontitis with clinical attachment loss >2mm, <5mm.

Exclusion criteria

Exclusion criteria: systemic or infectious diseases,insufficient platelet count for PRF preparation,intake of any mediations that will interfere with bloood clotting

Design outcomes

Primary

Measure	Time frame
Assess changes in periodontal clinical parameters: Plaque index, modified sulcular bleeding index, probing pocket depth, gingival marginal level, clinical attachment level and radiographic defect fill of the pariodontal defectTimepoint: baseline, 3 months, 6 months, 9 months	—

Secondary

Measure	Time frame
defect fillTimepoint: baseline,9 months	—

Countries

India

Contacts

Public ContactDrPresanthila janam

pjanamperio@gmail.com09387803891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026